US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

BTTX Better Therapeutics Inc

0.0446

0.00 (0.00%)

27 Jun 2024 - Cerrado

Retrasado por 15 minutos

Form D - Notice of Exempt Offering of Securities

Better Therapeutics (NASDAQ:BTTX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas Better Therapeutics.

Better Therapeutics (NASDAQ:BTTX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas Better Therapeutics.

Noticias sobre Better Therapeutics Inc BTTX

Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq
Jueves 14 de Marzo 2024 (4 meses hace) • Business Wire

Form 8-K - Current report
Lunes 11 de Marzo 2024 (4 meses hace) • Edgar (US Regulatory)

Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers
Martes 5 de Marzo 2024 (4 meses hace) • Business Wire

Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
Lunes 4 de Marzo 2024 (4 meses hace) • Business Wire

Form 8-K - Current report
Lunes 4 de Marzo 2024 (4 meses hace) • Edgar (US Regulatory)

Form RW - Registration Withdrawal Request
Viernes 1 de Marzo 2024 (4 meses hace) • Edgar (US Regulatory)

Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease
Martes 20 de Febrero 2024 (4 meses hace) • Business Wire

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Lunes 12 de Febrero 2024 (5 meses hace) • Edgar (US Regulatory)

Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment
Martes 6 de Febrero 2024 (5 meses hace) • Business Wire

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Martes 6 de Febrero 2024 (5 meses hace) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jueves 25 de Enero 2024 (5 meses hace) • Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities
Martes 23 de Enero 2024 (5 meses hace) • Edgar (US Regulatory)

Más de Better Therapeutics Inc Artículos de Noticias

Amex Exploration

Shinyoung Securities

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones